Lidocaine/Dextrose 5%/7.5% PF, manufactured by New England Compounding Center, Framingham, MA
New England Compounding Center
Class I - Dangerous
Lack of Assurance of Sterility
💊
Drugs Recalls
Prescription and over-the-counter medications
17,685 Total Recalls
Methylprednisolone Acetate 80 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA
New England Compounding Center
Class I - Dangerous
Non-Sterility
Dexamethasone Sodium Phosphate 4 mg/mL vials PF, 6 mg/mL PF vials, and 8 mg/mL PF vials, manufactured by New England Compounding Center, Framingham, MA
New England Compounding Center
Class I - Dangerous
Lack of Assurance of Sterility
Synthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90; ABBOTT LABORATORIES NORTH CHICAGO, IL 60064 U.S.A.
Abbott Laboratories
Class I - Dangerous
Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.
Hyaluronidase 150 u/ml PF, 1 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA
New England Compounding Center
Class I - Dangerous
Lack of Assurance of Sterility
Cymevene 500 mg Powder for Infusion, (ganciclovir), 50 mg/mL ganciclovir (reconstructed), Rx only, 10 mL vials, Roche Products Limited, Welwyn Garden City, AL7 1TW, United Kingdom
F. Hoffmann-LaRoche
Class I - Dangerous
Lack of Assurance of Sterility; container closure issues with the bulk batch.
Class I - Dangerous
Subpotent; 9-month stability interval
Class I - Dangerous
Subpotent; 9-month stability interval
Levothyroxine Sodium Tablets, USP, 175 mcg in 90 ct bottles, Manufactured by Patheon Puerto Rico Inc., for Alara Pharmaceutical Corp, San Juan, PR
Alara Pharmaceutical
Class I - Dangerous
Subpotent; 15 month stability
Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA
Lloyd Inc. of Iowa
Class I - Dangerous
Subpotent; 9-month stability interval
Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Lloyd Inc. of Iowa
Class I - Dangerous
Subpotent; 9-month stability interval
Procrit (epoetin alfa) injection, 20000 units/mL, 4 mL vial; Mfg By: Amgen Inc., Thousand Oaks, CA 91320; Dist. By: Physicians Total Care, Tulsa, OK 74146; NDC 54868-5673-1.
Physicians Total Care
Class I - Dangerous
Presence of Particulate Matter: glass delamination
Impurities/Degradation Products: Out-of-specification results were obtained for a known impurities.
Class I - Dangerous
Superpotent (Single Ingredient Drug): salicylic acid
Class I - Dangerous
Short Fill: some bottles contained less than 120-count per labeled claim.
Class I - Dangerous
Presence of Particulate Matter; potential for charcoal particulates
Class I - Dangerous
Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured.
Class I - Dangerous
Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the presence of particulate matter in the product.
Class I - Dangerous
Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.
Class I - Dangerous
Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.